• Dsip Peptide Delta Sleep-Inducing Peptide Somnogeneric Nonapeptide 62568-57-4 Disp Powder
  • Dsip Peptide Delta Sleep-Inducing Peptide Somnogeneric Nonapeptide 62568-57-4 Disp Powder
  • Dsip Peptide Delta Sleep-Inducing Peptide Somnogeneric Nonapeptide 62568-57-4 Disp Powder
  • Dsip Peptide Delta Sleep-Inducing Peptide Somnogeneric Nonapeptide 62568-57-4 Disp Powder
  • Dsip Peptide Delta Sleep-Inducing Peptide Somnogeneric Nonapeptide 62568-57-4 Disp Powder
  • Dsip Peptide Delta Sleep-Inducing Peptide Somnogeneric Nonapeptide 62568-57-4 Disp Powder

Dsip Peptide Delta Sleep-Inducing Peptide Somnogeneric Nonapeptide 62568-57-4 Disp Powder

CAS No.: 910463
Formula: 2079878
EINECS: 2079878
Certification: REACH, MSDS
Environmental Protection: Yes
Function: Rehabilitation
Samples:
US$ 1/Piece 1 Piece(Min.Order)
| Request Sample
Diamond Member Since 2024

Suppliers with verified business licenses

Manufacturer/Factory, Trading Company
  • Overview
  • Detailed Photos
  • Product Description
  • Product Parameters
  • Certifications
  • Packaging & Shipping
  • Company Profile
  • Our Advantages
  • FAQ
Overview

Basic Info.

Model NO.
62568-57-4
Appearance
Powder
Color
White
Name
Semag
Appearence
White Powder
Shelf Life
2 Years
Purity
99%
Package
Bottle or Foil Bag
Delivery Days
3 Days
Store
Cool and Dry Place
Transport Package
Vials
Specification
10mg per vial
Trademark
Yueqi
Origin
China
HS Code
2930909099
Production Capacity
50000

Product Description

Detailed Photos

Dsip Peptide Delta Sleep-Inducing Peptide Somnogeneric Nonapeptide 62568-57-4 Disp Powder

Dsip Peptide Delta Sleep-Inducing Peptide Somnogeneric Nonapeptide 62568-57-4 Disp PowderDsip Peptide Delta Sleep-Inducing Peptide Somnogeneric Nonapeptide 62568-57-4 Disp Powder
Product Description
What are the main efficacy and functions of Sema?
Sema is a glucagon like peptide-1 ( receptor agonist used to treat type 2 diabetes. It can lower blood glucose levels, increase Insuli secretion, inhibit gastrointestinal glucose absorption, and reduce liver glucose production by simulating the action of Insuli-like peptide-1. Smegg has also been studied for weight management. At higher doses, sema has been developed as a drug for the treatment of obesity. This drug has performed well in clinical trials, with significant therapeutic effects and high safety.

Semag is a new drug for diabetes treatment. Its unique mechanism and remarkable efficacy have attracted extensive attention in the medical community. This article will delve into the efficacy and effects of smeglutide, providing readers with a comprehensive understanding of this drug.
 
1. The powerful effect of reducing blood sugar levels

One of the main effects of smeg in the treatment of diabetes is its significant effect of reducing blood sugar levels. It is a
receptor agonist, which can stimulate Insuli release and inhibit glucagon release by simulating the effect of glucagon like peptide-1
), so as to effectively regulate blood glucose levels and help patients better manage diabetes.

 
2. Positive effects of promoting weight loss

Compared with some traditional diabetes drugs, smeg has obvious advantages in promoting weight loss. This is a beneficial feature for many patients with diabetes, especially those with obesity. By regulating appetite and promoting Insuli sensitivity, Smeg helps patients achieve effective weight control.
 
3. Positive effects on cardiovascular health

In addition to its direct effect in the treatment of diabetes, smeglutide also has a positive impact on cardiovascular health. Research shows that the incidence of cardiovascular events in patients using smeglutide is relatively low, which makes it an ideal choice for patients with diabetes and cardiovascular disease risk.
 
4. Long lasting efficacy and convenient medication methods

As a long-acting drug, the frequency of use of semais relatively low, which provides patients with a more convenient way of medication. Patients can maintain the effectiveness of medication through weekly injections, which is significantly helpful in improving medication adherence compared to oral medication taken multiple times a day.
 
epilogue

Smeg, as a new type of diabetes treatment drug, has brought new treatment options for diabetes patients with its multiple advantages such as reducing blood sugar, promoting weight loss, positive effects on cardiovascular health, and convenient medication. The use of any medication should be under the guidance of a doctor, and patients should pay attention to the doctor's advice when using smeglutide to ensure rational medication and achieve the best treatment effect.

  


Powder Form: Product may be stored up to 90 days at room temperature when in powder form. Shelf life 2 years when frozen (recommended) or kept refrigerated below 8o C (46o F).

Once Reconstituted To Liquid:

 
Product may be stored at room temperature (cool dark location) up to 10 days. Highly recommended to keep product refrigerated below 8o C (46o F). Do not freeze once reconstituted.

Product Parameters
  
Product name Semag
   
Molecular formula C187H291N45O59
Molecular weight 4113.57754
Appearance White powder
Purity 99.0%
Function Sema can reduces hunger, food craving and body fat.
Discribe Semag is a new generation 
(glucagon-like peptide-1) analogues. Semaglu is a long-acting dosage form based on the basic structure of liraglutide, which is more effective in the treatment of type 2 diabetes mellitus. Compared with lilarlutide, somalutide has a longer aliphobic chain and an increased hydrophobicity, but somalutide is modified with a short chain of PEG, and its hydrophilicity is greatly enhanced.PEG modification can not only tightly bind to albumin, cover up the DPP-4 enzymatic hydrolysis site, but also reduce renal excretion, prolong the biological half-life, and achieve the effect of long circulation.


Semag (USAN; trade name Ozempi'c) is a pharmaceutical drug in development by a Danish company Novo Nordisk for the treatment of type 2 diabetes. It is marketed by the name Ozempi'c. As a glucagon-like peptide-1 receptor agonist, it lowers the blood sugar level by increasing the production. It was discovered in 2012, by a team of researchers at Novo Nordisk as a longer-acting alternative to liraglutide. Clinical trials were started in 2015, and phase 3 was completed in 2016. FDA approval was applied in December 2016, and in October 2017 FDA Advisory Committee voted 16-0 in favour. It can be used as both injection-type or oral-type drug.
Researchers at the University of Leeds reported in 2017 that it can also be used for the treatment of obesity. It reduces hunger, food craving and body fat.
 
Certifications

Dsip Peptide Delta Sleep-Inducing Peptide Somnogeneric Nonapeptide 62568-57-4 Disp PowderDsip Peptide Delta Sleep-Inducing Peptide Somnogeneric Nonapeptide 62568-57-4 Disp Powder

Packaging & Shipping
Dsip Peptide Delta Sleep-Inducing Peptide Somnogeneric Nonapeptide 62568-57-4 Disp Powder
Dsip Peptide Delta Sleep-Inducing Peptide Somnogeneric Nonapeptide 62568-57-4 Disp Powder

 

Company Profile

tirzepa new material Co., LTD, established in 2017, It is an innovative high-tech enterprise with the core of enzyme catalysis technology in the field of synthetic biology and the interdisciplinary application of multidisciplinary technology.

Headquartered in Shenzhen Nanshan Science and Technology Ecological Park, Shenzhen has an excellent management team. The products are exported to Europe, the United States and Southeast Asia, and the market sales are increasing year by year.

The two major production bases are located in Jilin and Anhui respectively. The third major production base will officially start construction in early April 2025. As a powerful production-oriented enterprise, we truly integrate R&D, production and sales, with stable supply and quality for customers. And double guarantee of service.

Products are widely used in food, cosmetics, health products, medicine and other fields. The company advocates green production and has been committed to providing customers with better and more environmentally friendly products and services.

The production technologies such as glutathione and β -nicotinamide mononucleotide developed by the company are internationally leading, all of which are self-developed enzymatic technologies and have obtained a number of national patents. 11 years of research and development, a total of 19 Chinese invention patents and 2 international invention patents have been declared, of which 7 Chinese invention patents and 8 software copyrights have been authorized. At the same time, we have also applied for various product certificates, such as KOSHER, HALAL, ISO9001, FDA, etc.

Dsip Peptide Delta Sleep-Inducing Peptide Somnogeneric Nonapeptide 62568-57-4 Disp PowderDsip Peptide Delta Sleep-Inducing Peptide Somnogeneric Nonapeptide 62568-57-4 Disp Powder

Our Advantages

1.More Professional service in active pharmaceutical ingredients exporting field
2.Better manufacture ability
3.Various payment term to choose:T/T,Western Union,L/C,Paypal
4.High quality/Safe material/Competitive price
5.Small order available
6.Quickly response
7.More safe and fast transport
8.OEM design for all customers

FAQ

 

1. Are you a manufacturer or trading company?

A: We are a manufacturer and welcome to visit our factory.

2. How to confirm the product quality before place an order?

A: We can provide you with a sample. Also, we have the inspection report issued by the authoritative third-party testing agency.

 

3: What's your MOQ?

A: It depends on different products. We accept sample order. Also, for some products, we can provide you with a free sample.

 

4: Do you provide after-sales service?

A: We provide 24-hour customer service. If you encounter any product quality problems or transportation problems, please feel free to contact us

 

5: How about delivery time and method?

A: We usually ship within 3-5 working days after payments.

We can ship by sea, air, and express. It also can make door to door shipping.

 

6: How to solve the after-sale disputes?

A: We accept changing or refunding service if any quality problem.

Dsip Peptide Delta Sleep-Inducing Peptide Somnogeneric Nonapeptide 62568-57-4 Disp PowderDsip Peptide Delta Sleep-Inducing Peptide Somnogeneric Nonapeptide 62568-57-4 Disp Powder

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

You Might Also Like

Diamond Member Since 2024

Suppliers with verified business licenses

Manufacturer/Factory, Trading Company
Registered Capital
2000000 RMB
Plant Area
101~500 square meters